Athersys Inc (ATHXQ)

Currency in USD
0.000001
0.000000(0.00%)
Delayed Data·
ATHXQ Scorecard
Full Analysis
Stock generally trades with high price volatility
Trading near 52-week Low
Earnings results expected in 0 days
ATHXQ is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0000010.000001
52 wk Range
0.0000010.001000
Key Statistics
Prev. Close
0.000001
Open
0.000001
Day's Range
0.000001-0.000001
52 wk Range
0.000001-0.001
Volume
-
Average Volume (3m)
14.13K
1-Year Change
-99%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ATHXQ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Athersys Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Athersys Inc Company Profile

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company’s lead platform product includes MultiStem cell therapy, an allogeneic stem cell product for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. The company was founded in 1995 and is headquartered in Cleveland, Ohio. On September 24, 2024, the voluntary petition of Athersys, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy along with its affiliates on January 5, 2024.

Compare ATHXQ to Peers and Sector

Metrics to compare
ATHXQ
Peers
Sector
Relationship
P/E Ratio
0.0x−3.5x−0.5x
PEG Ratio
0.00−0.060.00
Price/Book
0.0x2.6x2.6x
Price / LTM Sales
0.0x10.2x3.3x
Upside (Analyst Target)
0.0%312.4%42.8%
Fair Value Upside
Unlock0.7%6.5%Unlock

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ATHXQ Income Statement

FAQ

What Stock Exchange Does Athersys Trade On?

Athersys is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Athersys?

The stock symbol for Athersys is "ATHXQ."

What Is the Athersys Market Cap?

As of today, Athersys market cap is 61.75.

What Is Athersys's Earnings Per Share (TTM)?

The Athersys EPS (TTM) is -1.89.

When Is the Next Athersys Earnings Date?

Athersys will release its next earnings report on 13 Aug 2025.

From a Technical Analysis Perspective, Is ATHXQ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Athersys Stock Split?

Athersys has split 1 times.

How Many Employees Does Athersys Have?

Athersys has 24 employees.

What is the current trading status of Athersys (ATHXQ)?

As of 06 Aug 2025, Athersys (ATHXQ) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.